Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


Articles published in Circ Res

Retrieve available abstracts of 113 articles:
HTML format



Single Articles


    July 2024
  1. GAO C, Xiong Z, Liu Y, Wang M, et al
    Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jul 16. doi: 10.1161/CIRCRESAHA.124.324706.
    PubMed     Abstract available


  2. LEE CJM, Foo RS
    TRIM35: A Proposed Gateway to p53-Induced Heart Failure Pathogenesis.
    Circ Res. 2024;135:314-316.
    PubMed    


  3. HINTON A JR, Claypool SM, Neikirk K, Senoo N, et al
    Mitochondrial Structure and Function in Human Heart Failure.
    Circ Res. 2024;135:372-396.
    PubMed     Abstract available


    June 2024
  4. ROMAN B, Mastoor Y, Sun J, Chapoy Villanueva H, et al
    MICU3 Regulates Mitochondrial Calcium and Cardiac Hypertrophy.
    Circ Res. 2024;135:26-40.
    PubMed     Abstract available


  5. LORENZANA-CARRILLO MA, Tejay S, Nanoa J, Huang G, et al
    TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure.
    Circ Res. 2024 Jun 11. doi: 10.1161/CIRCRESAHA.123.324202.
    PubMed     Abstract available


  6. MALLAREDY V, Roy R, Cheng Z, Gurrala CT, et al
    Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.
    Circ Res. 2024 Jun 7. doi: 10.1161/CIRCRESAHA.123.324110.
    PubMed     Abstract available


  7. ALCAIDE P, Kallikourdis M, Emig R, Prabhu SD, et al
    Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction.
    Circ Res. 2024;134:1752-1766.
    PubMed     Abstract available


    May 2024
  8. LIEM DA, Olivera da Silva H, Romero E, Rocha P, et al
    Association of Neighborhood and Environmental Factors with Clinical Phenotypes and Outcomes in Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2024 May 17. doi: 10.1161/CIRCRESAHA.124.324429.
    PubMed    


    April 2024
  9. QASIM H, Rajaei M, Xu Y, Reyes-Alcaraz A, et al
    AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
    Circ Res. 2024;134:1006-1022.
    PubMed     Abstract available


    March 2024
  10. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
    Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
    Circ Res. 2024;134:675-694.
    PubMed     Abstract available


  11. CURAJ A, Vanholder R, Loscalzo J, Quach K, et al
    Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
    Circ Res. 2024;134:592-613.
    PubMed     Abstract available


    February 2024
  12. KAMRADT ML, Makarewich CA
    CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
    Circ Res. 2024;134:442-444.
    PubMed    


  13. VACCA A, Schiattarella GG
    From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
    Circ Res. 2024;134:390-392.
    PubMed    


    January 2024
  14. WANG YC, Koay YC, Pan C, Zhou Z, et al
    Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jan 24. doi: 10.1161/CIRCRESAHA.123.322381.
    PubMed     Abstract available


    December 2023
  15. STEGE NM, Eijgenraam TR, Oliveira Nunes Teixeira V, Feringa AM, et al
    DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Circ Res. 2023;133:1006-1021.
    PubMed     Abstract available


    November 2023
  16. DAI Z, Thorp EB
    New Way to Study Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:899-901.
    PubMed    


  17. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
    Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:885-898.
    PubMed     Abstract available


  18. KWAN Z, Paulose Nadappuram B, Leung MM, Mohagaonkar S, et al
    Microtubule-Mediated Regulation of beta(2)AR Translation and Function in Failing Hearts.
    Circ Res. 2023;133:944-958.
    PubMed     Abstract available


    October 2023
  19. LIU D, Wang M, Murthy V, McNamara DM, et al
    Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis.
    Circ Res. 2023;133:810-825.
    PubMed     Abstract available


    September 2023
  20. SERIO S, Pagiatakis C, Musolino E, Felicetta A, et al
    Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis.
    Circ Res. 2023;133:687-703.
    PubMed     Abstract available


    July 2023

  21. Correction to: SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2023;133:e48.
    PubMed    


  22. TANG X, Zhao S, Liu J, Liu X, et al
    Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation.
    Circ Res. 2023;133:220-236.
    PubMed     Abstract available


  23. DAI Y, Ignatyeva N, Xu H, Wali R, et al
    An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes.
    Circ Res. 2023;133:e19-e46.
    PubMed     Abstract available


    June 2023
  24. FATKIN D, Ohanian M, Brown KJ
    A Novel Role for FKBP5 in Atrial Cardiomyopathy.
    Circ Res. 2023;133:45-47.
    PubMed    


  25. SANCHEZ-ALONSO JL, Fedele L, Copier JS, Lucarelli C, et al
    Functional LTCC-beta(2)AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure.
    Circ Res. 2023 Jun 14. doi: 10.1161/CIRCRESAHA.123.322508.
    PubMed     Abstract available


    May 2023
  26. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
    Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
    Circ Res. 2023;132:1468-1485.
    PubMed     Abstract available


  27. BOULOS PK, Freeman SV, Henry TD, Mahmud E, et al
    Interaction of COVID-19 With Common Cardiovascular Disorders.
    Circ Res. 2023;132:1259-1271.
    PubMed     Abstract available


    April 2023
  28. NGUYEN TD, Schulze PC
    Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Circ Res. 2023;132:1034-1049.
    PubMed     Abstract available


  29. WU Z, Lohmoller J, Kuhl C, Wehrle K, et al
    Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk.
    Circ Res. 2023;132:1084-1100.
    PubMed     Abstract available


    March 2023
  30. MATSUURA TR, Puchalska P, Crawford PA, Kelly DP, et al
    Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
    Circ Res. 2023;132:882-898.
    PubMed     Abstract available


  31. YE S, Huang H, Han X, Luo W, et al
    Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Circ Res. 2023;132:707-722.
    PubMed     Abstract available


  32. CANNAVO A, Jun S, Rengo G, Marzano F, et al
    beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
    Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
    PubMed     Abstract available


  33. HUGHES A, Shandhi MMH, Master H, Dunn J, et al
    Wearable Devices in Cardiovascular Medicine.
    Circ Res. 2023;132:652-670.
    PubMed     Abstract available


    February 2023
  34. YE B, Zhou H, Chen Y, Luo W, et al
    USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Circ Res. 2023;132:465-480.
    PubMed     Abstract available


  35. SAWICKI KT, De Jesus A, Ardehali H
    Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Circ Res. 2023;132:379-396.
    PubMed     Abstract available


  36. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    PubMed     Abstract available


    January 2023
  37. EL JAMAL N, Lordan R, Teegarden SL, Grosser T, et al
    The Circadian Biology of Heart Failure.
    Circ Res. 2023;132:223-237.
    PubMed     Abstract available


  38. RUBINO M, Travers JG, Headrick AL, Enyart BT, et al
    Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.
    Circ Res. 2023;132:10-29.
    PubMed     Abstract available


    December 2022
  39. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart Failure.
    Circ Res. 2022 Dec 28. doi: 10.1161/CIRCRESAHA.122.321326.
    PubMed     Abstract available


  40. DENG B, Zhang Y, Zhu C, Wang Y, et al
    Divergent Actions of Myofibroblast and Myocyte beta(2)-Adrenoceptor in Heart Failure and Fibrotic Remodeling.
    Circ Res. 2022 Dec 2. doi: 10.1161/CIRCRESAHA.122.321816.
    PubMed    


    October 2022
  41. WU X, Liu H, Brooks A, Xu S, et al
    SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2022 Oct 24. doi: 10.1161/CIRCRESAHA.121.318988.
    PubMed     Abstract available


    September 2022

  42. Correction to: Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022;131:e101.
    PubMed    


  43. ZHANG J, Gutierrez-Lara EJ, Liang Y, Sheikh F, et al
    Functions Beyond the Editor's I in Regulating Cardiac Innate Immunity and Heart Failure.
    Circ Res. 2022;131:598-600.
    PubMed    


  44. UMBARKAR P, Tousif S, Singh AP, Anderson JC, et al
    Fibroblast GSK-3alpha Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Circ Res. 2022;131:620-636.
    PubMed     Abstract available


  45. GARCIA-GONZALEZ C, Dieterich C, Maroli G, Wiesnet M, et al
    ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Circ Res. 2022;131:580-597.
    PubMed     Abstract available


  46. TIAN C, Gao L, Rudebush TL, Yu L, et al
    Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.
    Circ Res. 2022 Sep 13:101161CIRCRESAHA122320916.
    PubMed     Abstract available


    August 2022

  47. Correction to: Heart Failure with Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;131:e100.
    PubMed    


    July 2022
  48. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    PubMed    


    June 2022
  49. WANG X, Zhang G, Dasgupta S, Niewold EL, et al
    ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress.
    Circ Res. 2022;131:91-105.
    PubMed     Abstract available


  50. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022 Jun 14:101161CIRCRESAHA121319817.
    PubMed     Abstract available


  51. PILZ PM, Ward JE, Chang WT, Kiss A, et al
    Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
    Circ Res. 2022;130:1888-1905.
    PubMed     Abstract available


  52. ROH J, Hill JA, Singh A, Valero-Munoz M, et al
    Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;130:1906-1925.
    PubMed     Abstract available


  53. BUGGER H, Byrne NJ, Abel ED
    Animal Models of Dysregulated Cardiac Metabolism.
    Circ Res. 2022;130:1965-1993.
    PubMed     Abstract available


    May 2022
  54. MICHEL T, Nougue H, Cartailler J, Lefevre G, et al
    proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action.
    Circ Res. 2022;130:e44-e57.
    PubMed     Abstract available


  55. ZHU D, Zhang Z, Zhao J, Liu D, et al
    Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
    Circ Res. 2022 May 25:101161CIRCRESAHA121319976.
    PubMed     Abstract available


  56. PATEL KP, Katsurada K, Zheng H
    Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Circ Res. 2022;130:1601-1617.
    PubMed     Abstract available


  57. LIU J, Li W, Deng KQ, Tian S, et al
    The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
    Circ Res. 2022;130:1586-1600.
    PubMed     Abstract available


  58. TOMA A, Dos Santos C, Burzynska B, Gora M, et al
    Diversity in the Expressed Genomic Host Response to Myocardial Infarction.
    Circ Res. 2022 May 9:101161CIRCRESAHA121318391.
    PubMed    


    April 2022

  59. Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e25.
    PubMed    


  60. BRITTAIN EL, Hemnes AR
    Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
    Circ Res. 2022;130:1362-1364.
    PubMed    


  61. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed     Abstract available


  62. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed     Abstract available


  63. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed     Abstract available



  64. Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2022;130:e23.
    PubMed    


  65. MESUBI OO, Anderson ME
    Heart Failure and Atrial Fibrillation-Chicken or Egg?
    Circ Res. 2022;130:1011-1013.
    PubMed    


    March 2022
  66. WANG J, Shi Q, Wang Y, Dawson LW, et al
    Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice.
    Circ Res. 2022 Mar 23:CIRCRESAHA121320680. doi: 10.1161/CIRCRESAHA.121.320680.
    PubMed     Abstract available



  67. Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e21.
    PubMed    


  68. STACHOWSKI-DOLL MJ, Papadaki M, Martin TG, Ma W, et al
    GSK-3beta Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
    Circ Res. 2022;130:871-886.
    PubMed     Abstract available


  69. YAO Y, Li F, Zhang M, Jin L, et al
    Targeting CaMKII-delta9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
    Circ Res. 2022;130:887-903.
    PubMed     Abstract available


  70. MA K, Yang J, Shao Y, Li P, et al
    Therapeutic and Prognostic Significance of Arachidonic Acid in Heart Failure.
    Circ Res. 2022 Mar 8:CIRCRESAHA121320548. doi: 10.1161/CIRCRESAHA.121.320548.
    PubMed     Abstract available


    February 2022
  71. DEFILIPPIS EM, Beale A, Martin T, Agarwal A, et al
    Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:436-454.
    PubMed     Abstract available


  72. KECELI G, Gupta A, Sourdon J, Gabr R, et al
    Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
    Circ Res. 2022 Feb 3:CIRCRESAHA121319648. doi: 10.1161/CIRCRESAHA.121.319648.
    PubMed     Abstract available


    January 2022
  73. SOSSALLA S, Bers DM
    Neuron-Restrictive Silencer Factor Limits Myocyte GalphaO Expression and Is Protective in Heart Failure Progression.
    Circ Res. 2022;130:249-251.
    PubMed    


  74. SHEA S, Blaha MJ
    Long-Term Risk Prediction for Heart Failure, Disparities, and Early Prevention.
    Circ Res. 2022;130:210-212.
    PubMed    


  75. INAZUMI H, Kuwahara K, Nakagawa Y, Kuwabara Y, et al
    NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca(2+) Homeostasis.
    Circ Res. 2022;130:234-248.
    PubMed     Abstract available


    December 2021
  76. KHAN SS, Ning H, Allen NB, Carnethon M, et al
    Development and Validation of A Long-Term Incident Heart Failure Risk Model.
    Circ Res. 2021 Dec 10. doi: 10.1161/CIRCRESAHA.121.319595.
    PubMed     Abstract available


    October 2021

  77. Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021;129:e201.
    PubMed    


  78. SOETKAMP D, Gallet R, Parker SJ, Holewinski R, et al
    Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.
    Circ Res. 2021 Oct 13. doi: 10.1161/CIRCRESAHA.119.316311.
    PubMed     Abstract available


    September 2021
  79. WANG Y, Zhao M, Shi Q, Xu B, et al
    Monoamine Oxidases Desensitize Intracellular beta1AR Signaling in Heart Failure.
    Circ Res. 2021 Sep 17. doi: 10.1161/CIRCRESAHA.121.319546.
    PubMed    


    August 2021
  80. RONG J, Tao X, Lin Y, Zheng H, et al
    Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction.
    Circ Res. 2021;129:547-564.
    PubMed     Abstract available


    July 2021
  81. YURA Y, Miura-Yura E, Katanasaka Y, Min KD, et al
    The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021 Jul 28. doi: 10.1161/CIRCRESAHA.121.319314.
    PubMed     Abstract available


  82. PADULA SL, Yutzey KE
    Epigenetic Regulation of Heart Failure: Cell Type Matters.
    Circ Res. 2021;129:414-416.
    PubMed    


    June 2021
  83. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    PubMed     Abstract available


  84. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    PubMed     Abstract available


    May 2021
  85. AKAR FG, Young LH
    NAD Repletion Therapy: A Silver Bullet for HFpEF?
    Circ Res. 2021;128:1642-1645.
    PubMed    


  86. RURIK JG, Aghajanian H, Epstein JA
    Immune Cells and Immunotherapy for Cardiac Injury and Repair.
    Circ Res. 2021;128:1766-1779.
    PubMed     Abstract available


  87. BURKE RM, Dirkx RA Jr, Quijada P, Lighthouse JK, et al
    Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
    Circ Res. 2021;128:1663-1678.
    PubMed     Abstract available


  88. FAN J, Li H, Xie R, Zhang X, et al
    LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy.
    Circ Res. 2021;128:1708-1723.
    PubMed     Abstract available


  89. ROGER VL
    Epidemiology of Heart Failure: A Contemporary Perspective.
    Circ Res. 2021;128:1421-1434.
    PubMed     Abstract available


  90. NJOROGE JN, Teerlink JR
    Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
    Circ Res. 2021;128:1468-1486.
    PubMed     Abstract available


  91. LOPASCHUK GD, Karwi QG, Tian R, Wende AR, et al
    Cardiac Energy Metabolism in Heart Failure.
    Circ Res. 2021;128:1487-1513.
    PubMed     Abstract available


  92. HAHN VS, Zhang KW, Sun L, Narayan V, et al
    Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
    Circ Res. 2021;128:1576-1593.
    PubMed     Abstract available


  93. MANN DL, Felker GM
    Mechanisms and Models in Heart Failure: A Translational Approach.
    Circ Res. 2021;128:1435-1450.
    PubMed     Abstract available


  94. PAULUS WJ, Zile MR
    From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Circ Res. 2021;128:1451-1467.
    PubMed     Abstract available


  95. MANN DL
    Heart Failure 2021: A Compendium of Translational Success.
    Circ Res. 2021;128:1419-1420.
    PubMed    


  96. BURKHOFF D, Topkara VK, Sayer G, Uriel N, et al
    Reverse Remodeling With Left Ventricular Assist Devices.
    Circ Res. 2021;128:1594-1612.
    PubMed     Abstract available


    April 2021
  97. BLASER MC, Kraler S, Luscher TF, Aikawa E, et al
    Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
    Circ Res. 2021;128:1371-1397.
    PubMed     Abstract available


  98. TONG D, Schiattarella GG, Jiang N, Altamirano F, et al
    NAD(+) Repletion Reverses Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2021 Apr 22. doi: 10.1161/CIRCRESAHA.120.317046.
    PubMed     Abstract available


  99. BOUTOUYRIE P, Chowienczyk P, Humphrey JD, Mitchell GF, et al
    Arterial Stiffness and Cardiovascular Risk in Hypertension.
    Circ Res. 2021;128:864-886.
    PubMed     Abstract available


    February 2021
  100. CHEN K, Wang S, Sun QW, Zhang B, et al
    Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway.
    Circ Res. 2021;128:492-507.
    PubMed     Abstract available


  101. MUSTROPH J, Sag CM, Bahr F, Schmidtmann AL, et al
    Loss of CASK Accelerates Heart Failure Development.
    Circ Res. 2021 Feb 17. doi: 10.1161/CIRCRESAHA.120.318170.
    PubMed     Abstract available


  102. TAEGTMEYER H
    Heart Failure in Diabetes: Still a Vexing Problem.
    Circ Res. 2021;128:358-359.
    PubMed    


  103. MANGNER N, Garbade J, Heyne E, van den Berg M, et al
    Molecular Mechanisms of Diaphragm Myopathy in Humans with Severe Heart Failure.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318060.
    PubMed     Abstract available


  104. LIU T, Yang N, Sidor A, O'Rourke B, et al
    MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca(2+) Leak.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318562.
    PubMed     Abstract available


    January 2021
  105. EVANS MA, Walsh K
    A Single-Cell Analysis of DNMT3A-Mediated Clonal Hematopoiesis in Heart Failure.
    Circ Res. 2021;128:229-231.
    PubMed    


  106. DENG Y, Xie M, Li Q, Xu X, et al
    Targeting Mitochondria-Inflammation Circuit by beta-Hydroxybutyrate Mitigates HFpEF.
    Circ Res. 2021;128:232-245.
    PubMed     Abstract available


  107. PERESTRELO AR, Silva AC, Oliver-De La Cruz J, Martino F, et al
    Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Circ Res. 2021;128:24-38.
    PubMed     Abstract available


  108. PAPA A, Kushner J, Hennessey JA, Katchman AN, et al
    Adrenergic CaV1.2 Activation via Rad Phosphorylation Converges at alpha1C I-II Loop.
    Circ Res. 2021;128:76-88.
    PubMed     Abstract available


    December 2020
  109. WITTENBECHER C, Eichelmann F, Toledo E, Guasch-Ferre M, et al
    Lipid Profiles and Heart Failure Risk: Results from Two Prospective Studies.
    Circ Res. 2020 Dec 4. doi: 10.1161/CIRCRESAHA.120.317883.
    PubMed     Abstract available


    November 2020
  110. ABPLANALP WT, Cremer S, John D, Hoffmann J, et al
    Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Circ Res. 2020 Nov 6. doi: 10.1161/CIRCRESAHA.120.317104.
    PubMed     Abstract available


    July 2020
  111. SHOEMAKER MB, Roden DM
    Atrial Fibrillation Is a Complex Trait: Very Complex.
    Circ Res. 2020;127:244-246.
    PubMed    


    May 2020
  112. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
    EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
    Circ Res. 2020;126:e97-e113.
    PubMed     Abstract available


    March 2020
  113. JOLY JM, Tallaj JA
    The Heart of the (Gray) Matter Is not Black and White.
    Circ Res. 2020;126:765-766.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.